Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.59 |
| ▸ | CA7 | P43166 | 2/20 | 0.59 |
| ▸ | CA9 | Q16790 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.46 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.46 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.43 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.43 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17911629 | 0.91 | KMT2A (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8609919 | 0.82 | KMT2A (0.60) | CA1CA2CA7CA9CA12 | |
| SCHEMBL1592406 | 0.81 | CA1 (0.65) | CA1CA2CA7CA9CA12 | |
| SCHEMBL31433095 | 0.81 | CA1 (0.65) | CA1CA2CA7CA9CA12 | |
| SCHEMBL105697 | 0.81 | CA1 (0.65) | CA1CA2CA7CA9CA12 | |
| SCHEMBL11749913 | 0.80 | SMN1; SMN2 (0.47) | CA1CA2CA7CA9CA12 | |
| 1,2-Dimethoxybenzene SCHEMBL28805731 | 0.78 | CA1 (0.77) | CA1CA2CA7CA9CA12 | |
| SCHEMBL227527 | 0.77 | NISCH (0.45) | KMT2AMAPK1L3MBTL1ADRA2BTSHR | |
| SCHEMBL24926175 | 0.77 | CA1 (0.59) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8747982 | 0.77 | CA1 (0.59) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009116069-A2 | PROCESS FOR PREPARATION OF 1-(9H-CARBAZOL-4-YLOXY)-3-[[2-(2- METHOXYPHENOXY) ETHYL] AMINO]-2-PROPANOL | IPCA LABORATORIES LIMITED (IN) | 2009-09-24 | — | — | WO | claimed |
| US-20100197813-A1 | Heterocyclic Compounds as Sweetener Enhancers | REDPOINT BIO CORPORATION (US) | 2010-08-05 | — | — | US | disclosed |
| US-7674831-B2 | Heterocyclic compounds as sweetener enhancers | REDPOINT BIO CORPORATION (US) | 2010-03-09 | — | — | US | disclosed |
| WO-2009128088-A2 | PREPARATION OF 2-(2-ALKOXY PHENOXY) ETHYLAMINE, AN INTERMEDIATE OF CARVEDILOL AND TAMSULOSIN | SHODHANA LABORATORIES LIMITED (IN) | 2009-10-22 | — | — | WO | disclosed |
| US-20080249189-A1 | HETEROCYCLIC COMPOUNDS AS SWEETENER ENHANCERS | REDPOINT BIO CORPORATION | 2008-10-09 | — | — | US | disclosed |
| EP-1506156-A1 | METHOD FOR PREPARING 2-ALKOXYPHENOXYETHANAMINES FROM 2-ALKOXYPHENOXYETHYLACETAMIDES | MCM PHARMA GMBH (DE) | 2005-02-16 | — | — | EP | disclosed |
| WO-2003095416-A1 | METHOD FOR PREPARING 2-ALKOXYPHENOXYETHANAMINES FROM 2-ALKOXYPHENOXYETHYLACETAMIDES | MCM PHARMA GMBH (DE) | 2003-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249189-A1 | HETEROCYCLIC COMPOUNDS AS SWEETENER ENHANCERS | TAS2R1, TAS1R1, TAS2R40 | CA1 1521/4885CA2 1398/4885CA7 845/4885 |
| US-20100197813-A1 | Heterocyclic Compounds as Sweetener Enhancers | TAS2R1, TAS1R1, TAS2R40 | CA1 1521/4885CA2 1398/4885CA7 845/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.